Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Cash Flow-to-Debt Ratio
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥117.38 Million could theoretically repay 0% of its total liabilities (CN¥2.44 Billion) in one year. Explore 600436 long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 25 annual periods. Also explore Zhangzhou Pientzehuang Pharmaceutical Co assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Year-by-year debt coverage analysis for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see market cap of Zhangzhou Pientzehuang Pharmaceutical Co.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | CN¥77.03 Million | CN¥2.47 Billion | ▼ -93.6% |
| 2024 | 0.49x | CN¥1.31 Billion | CN¥2.70 Billion | ▼ -30.3% |
| 2023 | 0.70x | CN¥2.21 Billion | CN¥3.16 Billion | ▼ -71.8% |
| 2022 | 2.47x | CN¥6.87 Billion | CN¥2.78 Billion | ▲ +1161.5% |
| 2021 | 0.20x | CN¥462.27 Million | CN¥2.36 Billion | ▼ -74.0% |
| 2020 | 0.75x | CN¥1.47 Billion | CN¥1.95 Billion | ▲ +257.6% |
| 2019 | -0.48x | CN¥-879.37 Million | CN¥1.84 Billion | ▼ -205.3% |
| 2018 | 0.45x | CN¥612.31 Million | CN¥1.35 Billion | ▼ -18.1% |
| 2017 | 0.55x | CN¥676.93 Million | CN¥1.22 Billion | ▲ +80.6% |
| 2016 | 0.31x | CN¥394.54 Million | CN¥1.29 Billion | ▼ -24.6% |
| 2015 | 0.41x | CN¥305.51 Million | CN¥751.60 Million | ▲ +1.8% |
| 2014 | 0.40x | CN¥264.50 Million | CN¥662.34 Million | ▼ -2.9% |
| 2013 | 0.41x | CN¥274.34 Million | CN¥667.05 Million | ▲ +71.0% |
| 2012 | 0.24x | CN¥162.40 Million | CN¥675.22 Million | ▼ -60.8% |
| 2011 | 0.61x | CN¥232.95 Million | CN¥379.69 Million | ▲ +8.4% |
| 2010 | 0.57x | CN¥205.41 Million | CN¥362.97 Million | ▲ +86.7% |
| 2009 | 0.30x | CN¥129.52 Million | CN¥427.35 Million | ▲ +667.6% |
| 2008 | 0.04x | CN¥12.57 Million | CN¥318.45 Million | ▼ -86.1% |
| 2007 | 0.28x | CN¥60.04 Million | CN¥212.03 Million | ▼ -38.8% |
| 2006 | 0.46x | CN¥50.70 Million | CN¥109.53 Million | ▼ -42.6% |
| 2005 | 0.81x | CN¥69.06 Million | CN¥85.56 Million | ▼ -83.9% |
| 2004 | 5.01x | CN¥98.67 Million | CN¥19.69 Million | ▲ +541.1% |
| 2003 | 0.78x | CN¥32.36 Million | CN¥41.40 Million | ▲ +26.7% |
| 2002 | 0.62x | CN¥105.45 Million | CN¥170.99 Million | ▲ +16.5% |
| 2001 | 0.53x | CN¥65.84 Million | CN¥124.34 Million | — |